×ÉѯÈÈÏß
18616108315
18616108315
²úÎï·ÖÀà
Product CategoryÏêϸ½éÉÜ
| Æ·ÅÆ | ³¢¾±´Ú±ð-¾±³¢²¹²ú/Àî¼ÇÉúÎï |
|---|
±«²Ñ¸é-106£¨´óÊó¹ÇÈâÁöϸ°û£©ÃèÊö
UMR-106£¨ÖÐÎÄÃû³Æ£º´óÊó¹ÇÈâÁöϸ°û£©£¬À´Ô´ÓÚ´óÊó¹ÇÈâÁöϸ°û£¬Õý³£µÄϸ°ûÐÎ̬ΪÉÏƤϸ°ûÑù£¬Ìù±ÚÉú³¤¡£
¶©¹ºÐÅÏ¢
²úÎïÃû³Æ | »õºÅ | ¹æ¸ñ |
UMR-106 | AX41L205 | T25/1 mL |
ÔËÊ䷽ʽ
³£ÎÂ/¸É±ùÔËÊä¡£
±«²Ñ¸é-106£¨´óÊó¹ÇÈâÁöϸ°û£©Ê¹Ó÷½·¨
ÅàÑø·½·¨
ÅàÑø»ù | DMEM £¨GIBCO: C11965500BT£©90%£¬ Fetal Bovine Serum(¸ßÆ·ÖÊ̥ţѪÇå) »òºÍÔªÀî¼ÇÌؼ¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£© 20% |
ÅàÑøÌõ¼þ | 37¡æ 5% CO2 |
Ïû»¯Ìõ¼þ | 0.25% (w/v) Trypsin-0.53 mM EDTAÈÜÒº£¬Ïû»¯1-3min |
´«´ú±ÈÀý | 1£º2-1£º4 |
»»ÒºÊ±¼ä | 2-3Ìì»»ÒºÒ»´Î |
¶³´æ·½·¨
¶³´æÒº | 55%ÅàÑø»ù£¬40%FBS, 5% (v/v) DMSO »ò ºÍÔªÀî¼Ç¿ìËÙϸ°û¶³´æÒº£¨ÎÞѪÇå¡¢ÎÞµ°°×£©£¨»õºÅ£ºAC05L033£© |
¶³´æÃÜ¶È | 1-3 ¡Á106 /¹Ü£¬Òºµª±£´æ |
¡¡ ¾ßÌå²Ù×÷·½·¨¼ûϸ°ûʹÓÃ˵Ã÷Êé
×¢ÒâÊÂÏî
±¾²úÎï½öÏÞÓÚ¿ÆѧʵÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
µ±ÊÕµ½Ï¸°ûºó£¬Çë×ÐϸÔĶÁϸ°ûʹÓÃ˵Ã÷Ê飬°´¹æ¶¨²Ù×÷²¢¼Ç¼ϸ°û״̬£¨ÅÄÕÕ£©¡£ÎÒ˾Ϊ¿Í»§ÌṩһÖÜÄÚµÄÊÛºó±£ÕÏ£¬Ìض¨Çé¿öÏ¿ÉÃâ·ÑÖØ·¢Ï¸°û¡£
²Î¿¼ÎÄÏ×
Banerjee C, et al. An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteoclacin gene. Proc. Natl. Acad. Sci. USA 93: 4968-4973, 1996. PubMed: 8643513
.Endocrinology of calcium metabolism. Amsterdam: Elsevier/North Holland; 1977.
Atkins D, et al. Rat osteogenic sarcoma cells: modulation of hormone stimulated cyclic AMP production by prostaglandin antagonists and biosynthesis inhibitors. Clin. Exp. Pharmacol. Physiol. 7: 31-44, 1980. PubMed: 6103768
Manolagas SC, Deftos LJ. Cytoreceptor assay for 1,25-dihydroxyvitamin D3: a novel radiometric method based on binding of the hormone to intracellular receptors in vitro. Lancet 2: 401-402, 1980. PubMed: 6105521
Partridge NC, et al. Receptors for 1,25(OH)2-vitamin D3 enriched in cloned osteoblast-like rat osteogenic sarcoma cells. FEBS Lett. 115: 139-142, 1980. PubMed: 6248375
Ïà¹Ø²úÎïÍƼö
Ìؼ¶Ì¥Å£ÑªÇå (Foetal Bovine Serum)£¨»õºÅ£ºAC03L055£©
RPMI-1640 medium (º¬L-¹È°±µÄõ£°·)£¨»õºÅ£ºAC01L064£©
±¾²úÎï½öÏÞÓÚ¿ÆѧʵÑéÑо¿Ê¹Ó㬲»µÃÓÃÓÚÁÙ´²Õï¶Ï¡¢ÖÎÁƵÈÁìÓò¡£
²úÎï×Éѯ
΢ÐÅ×Éѯµç»°
΢ÐÅ×Éѯ
¹Ø×¢¹«ÖÚºÅ
µ±Ç°Î»Öãº
